Nov 18, 2026

The Ultimate Guide to Valuation of Sweat Equity in India

Share on

1. What Is Sweat Equity?

Sweat equity refers to the non-monetary contribution made by founders, employees, or directors to a company, typically in exchange for equity shares. Unlike financial equity where investors put in money, sweat equity is earned through time, expertise, intellectual property, innovation, or value-added services rendered to the company.

In simple terms: if you build a product, design a brand, write code, or hustle to grow a startup and you receive shares for that effort instead of (or in addition to) cash those shares are your sweat equity.

For instance, when a HealthTech co-founder puts in ₹50 lakh in capital while her technical co-founder contributes no cash but builds the entire platform over 18 months, the company might issue the technical co-founder 30% equity in recognition of that work equity earned through skill and effort rather than money is her sweat equity.

What makes sweat equity uniquely complex from a valuation standpoint is that it requires the Registered Valuer to simultaneously answer two separate questions: what is the company worth per share today, and what is the non-cash contribution actually worth? Both questions demand independent, methodology-backed answers  and the proportionality between the two is the cornerstone of a defensible valuation report.

1.1 Why Does Sweat Equity Matter?

• Allows cash-strapped startups to attract talent without burning runway

• Aligns founder and employee incentives with company performance

• Recognises intellectual contributions (IP, patents, know-how) as valuable assets

• Creates long-term stakeholder commitment and reduces attrition

1.2 Sweat Equity vs. ESOPs  The Key Difference

Feature

Sweat Equity Shares

ESOPs (Stock Options)

Nature

Direct allotment of shares

Option/right to buy shares later

Recipient

Directors & employees (current)

Employees (current & future)

Consideration

Non-cash (skills / IP / services)

Usually cash at exercise price

Governing Law

Section 54, Companies Act 2013

Section 62(1)(b), Companies Act 2013

Valuation Required?

Yes, dual valuation: (1) FMV per share via DCF/CCM/NAV and (2) non-cash contribution via RfR/MEEM/Cost-to-Recreate. Both required.

Yes, at the time of grant of the option.

2. Regulatory Context

An understanding of the key regulatory requirements is essential context for any valuation engagement. This section covers only the provisions directly relevant to the valuation process. For full compliance requirements including board resolutions, ROC filings, and tax obligations  readers should consult their legal and tax advisors.

2.1 Companies Act, 2013: Section 54 (Key Valuation-Relevant Points)

• A Special Resolution in General Meeting is required, specifying the number of shares and the basis of valuation.

• Issuance is capped at 15% of existing paid-up equity share capital per year, or shares of the issue value of ₹5 crore, whichever is higher. Cumulative cap: 25% of paid-up equity capital.

• DPIIT-recognised start-ups: the 25% cumulative cap is relaxed to 50% for the first 5 years creating significantly more flexibility for early-stage companies.

• The company must have been in existence for at least one year (except DPIIT-recognised start-ups).

2.2 SEBI Regulations: Listed Companies (Valuation-Relevant Points)

• Component 1 (FMV per share): The SEBI VWAP formula  average of weekly high and low of volume-weighted average prices for the 6-month or 2-week period preceding the relevant date, whichever is higher is the mandatory pricing floor. The valuer cannot conclude below this price.

• Component 2 (value of non-cash contribution): the SEBI price formula covers only Component 1. The IP, know-how or value addition must still be independently valued by a SEBI Merchant Banker using the methods in Section 5 (RfR, Cost-to-Recreate, MEEM, Market Benchmarking, NPV of Cost Savings), with a report addressed to the Board. The grant value (SEBI price × shares) must then be reconciled with this Component 2 value, so that the number of shares issued is supported by the contribution.

• Lock-in of 3 years from allotment date directly affects the Discount for Lack of Marketability (DLOM) calculation a forced lock-in increases illiquidity and justifies the upper end of the applicable DLOM range.

2.3 Who Can Receive Sweat Equity?

Section 54 of the Companies Act, 2013 permits sweat equity shares to be issued only to the company’s directors or employees, for providing know-how or making available intellectual property rights or value additions. The class of persons eligible must be specified in the Special Resolution, so the valuer should first confirm that the proposed recipient falls within it.

• Directors: whole-time and non-executive directors can receive sweat equity. For listed companies, independent directors are generally not eligible.

• Employees: Rule 8 of the Companies (Share Capital and Debentures) Rules, 2014 covers employees working in India or outside India. Employees of a subsidiary, holding or associate company are generally also covered. The SEBI SBEB & SE Regulations, 2021 no longer restrict sweat equity to “permanent” employees, so fixed-term employees are not excluded on that basis alone.

• Founders and promoters: in an unlisted company there is no bar, and founders commonly receive sweat equity as directors or employees. In a listed company, the eligibility of promoters, the promoter group and 10%+ shareholders should be confirmed against the SEBI definition in force on the relevant date.

• Not eligible: external consultants, vendors, advisors and investors who are neither directors nor employees. Shares allotted to them for a non-cash contribution must follow Section 62(1)(c) (preferential allotment, valued by a Registered Valuer) instead of Section 54.

• Company-level conditions: the company must have been in existence for at least one year (except DPIIT-recognised start-ups), pass a Special Resolution, and stay within the annual and cumulative caps described in 2.1.

2.4 Valuation: Listed vs. Unlisted Companies

Both components of the framework (Section 3) apply to every sweat equity issue. What differs is how Component 1 is determined and who values what.

Aspect

Listed Company

Unlisted Company

Governing framework

Section 54 and Rule 8, plus SEBI (SBEB & SE) Regulations, 2021 and listing requirements

Section 54 and Rule 8 of the Share Capital Rules

Component 1: value per share

Market-based price prescribed by SEBI, which is a mandatory floor (see 2.2). Quoted prices are observable, so DCF or CCA cannot be used to conclude below the floor.

Fair value determined by an IBBI Registered Valuer using DCF, CCM/CCA, NAV, or Berkus/VC and funding-round methods for early-stage companies (Section 4).

Component 2: value of contribution

Independent valuation of the IP, know-how or value addition by a SEBI Merchant Banker, using the Section 5 methods.

Valued by the IBBI Registered Valuer under Rule 8(2), with a report addressed to the Board justifying the value.

Discounts

Cannot take the value below the SEBI floor. The 3-year lock-in is still relevant when assessing the economic value to the recipient.

DLOM (reflecting the 3-year lock-in) and DLOC are applied where supported by evidence.

Valuation date

“Relevant date” as defined in the SEBI Regulations

Date specified in the Special Resolution, kept close to the allotment date

Disclosure

Explanatory statement to shareholders and stock exchange disclosures

Explanatory statement to shareholders; valuation report on file for filings

2.5 Can an Indian Company Issue Sweat Equity to a Foreign Employee?

 Yes. The Companies Act does not limit sweat equity to resident employees, and Rule 8 expressly covers employees working outside India. Under FEMA, Rule 8 of the Non-Debt Instruments Rules, 2019 allows an Indian company to issue sweat equity shares to employees and directors resident outside India, including those of its holding company, joint venture or wholly owned overseas subsidiary. Conditions generally include:

• The issue complies with the Companies Act, the Share Capital Rules and SEBI regulations (for listed companies).

• The issue is within the sectoral cap and entry route. Where the sector is on the Government route, prior Government approval is needed.

• Prior Government approval is required if the recipient is a citizen of Bangladesh or Pakistan.

• Reporting to the AD bank through FIRMS, generally Form FC-GPR within 30 days of allotment.

• The recipient’s home-country tax treatment and any foreign exchange or securities rules there should be reviewed separately.

How is it valued? The two-component framework is unchanged, with these additions:

• Listed company: Component 1 is the SEBI-prescribed price. Component 2 is valued by a SEBI Merchant Banker.

• Unlisted company: Component 1 is determined by the Registered Valuer under the Companies Act. FEMA pricing guidelines also apply to shares issued to a non-resident, with fair value determined under an internationally accepted pricing methodology and certified by the person FEMA prescribes (generally not older than 90 days). The rules do not clearly exempt sweat equity from this, so the valuation report should be structured to satisfy both regimes, and the AD bank’s view should be obtained in writing before issue.

• Component 2: the contribution is valued by the same methods (RfR, Cost-to-Recreate, MEEM, etc.). For work done abroad, confirm that the IP is legally assigned to the Indian company, use royalty benchmarks and wage rates relevant to where the work was performed, and convert foreign-currency inputs to INR at the rate on the valuation date.

2.6 Can a Foreign Company Issue Sweat Equity to an Indian Employee?

Yes, in principle. Section 54 applies only to Indian companies, so the issue is governed mainly by the law of the foreign company’s home country (its corporate, securities and tax rules). From the Indian side, the following apply:

• FEMA: under the Overseas Investment Rules, 2022 (Schedule III), a resident individual employed by the Indian office, branch or subsidiary of an overseas entity can receive its shares or options. A non-controlling holding of up to 10% is generally treated as overseas portfolio investment. If the employee pays any cash, the Liberalised Remittance Scheme limit (USD 250,000 per financial year) applies. Reporting by the Indian employer and the AD bank’s requirements should be confirmed.

• Income tax: the value received is generally taxed in India as a perquisite at allotment, on a fair market value computed under the Income-tax Rules in force. The shares must be disclosed in the employee’s return as foreign assets, and credit for foreign tax paid should be reviewed.

How is it valued?

• Component 1: for a foreign-listed company, the quoted price on its exchange is the starting point, converted into INR at the prescribed rate. For Indian tax purposes, the rules prescribe how fair market value is fixed for shares listed overseas. For an unlisted foreign company, the value is determined by the DCF/CCA/NAV methods in Section 4, and the Indian tax rules generally require a valuation by an Indian Category I Merchant Banker for perquisite computation.

• Component 2: the Section 5 methods apply, benchmarked to the market in which the employee works. The contribution should be attributed to the legal entity (Indian subsidiary or foreign parent) that actually benefits from it.

• Registered Valuer: a Companies Act Registered Valuer is not mandated by Section 54 here, but an Indian valuation is useful for tax, FEMA and any cost recharge from the parent to the Indian entity.

Cross-border rules are amended frequently. The company should confirm the current FEMA and tax position with its AD bank and advisors before issuing.

Tax implications of sweat equity including perquisite taxation at allotment and capital gains on sale  should be reviewed with your tax advisor. This guide focuses entirely on valuation methodology.

3. The Two-Component Framework

Every sweat equity valuation regardless of company stage, sector, or contribution type requires the Registered Valuer to simultaneously answer two distinct questions. These are not the same question, and they cannot be answered by a single methodology.

COMPONENT 1

Fair Market Value of the Equity Share

What is each share worth on the allotment date?

Methods:

• Discounted Cash Flow (DCF)

• Comparable Company Analysis (CCA/CTA)

• Net Asset Value / Adjusted Book Value

• Berkus Method / VC Method (pre-revenue)

• SEBI VWAP Formula (listed companies; mandatory floor)

COMPONENT 2

Value of the Non-Cash Contribution

What is the recipient’s contribution actually worth?

Methods:

• Relief from Royalty (RfR)  formal IP/patents

• Cost-to-Recreate  software, code, systems

• Multi-Period Excess Earnings (MEEM)  complex IP

• Market Benchmarking  advisory/expertise/know-how

• NPV of Cost Savings  process improvements

The equity grant value (Component 1 × shares issued) must be reconciled against Component 2: when Component 2 is greater than or equal to Component 1, the grant is proportionate and defensible. A grant materially exceeding contribution value requires explicit written justification in the report and often signals a structural problem with the transaction. For unlisted companies, a single IBBI Registered Valuer values both components; for listed companies, the SEBI Merchant Banker values Component 2 while the SEBI VWAP formula is mandatory for Component 1.

4. Component 1: Valuing Equity Share

These methods determine the fair market value per share on the allotment date. The appropriate method depends on company stage, data availability, and whether the company is listed or unlisted.

4.1 Net Asset Value (NAV) / Book Value Method

Suitable for: Companies where the primary value driver is current assets rather than future earning power (e.g., asset-heavy businesses, holding companies, early-stage pre-product companies).

FMV per share is calculated as (Total Assets − Total Liabilities) ÷ Total Number of Shares. NAV is inappropriate as a standalone method for technology or SaaS companies where future earning power, not current assets, drives value  using it for a funded startup will systematically understate FMV per share and invite Income Tax Department scrutiny.

4.2 Discounted Cash Flow (DCF) Method

Suitable for: Growth-stage companies with predictable future revenues. This is the most commonly used method for funded startups.

The DCF method projects future free cash flows and discounts them to present value using a Weighted Average Cost of Capital (WACC), then adds a terminal value based on a sustainable long-term growth rate which should not exceed India’s long-term nominal GDP growth of roughly 5–6%, since a higher rate overstates terminal value and invites challenge in due diligence.

4.3 Comparable Company / Market Multiples Method (CCA)

Suitable for: Companies with comparable listed peers or where industry multiples are available. Common multiples used in India: EV/Revenue, EV/EBITDA, P/E, Price/Book.

The Comparable Company Method (CCM) benchmarks the subject company’s revenue or earnings against the median multiple observed across listed peers, then applies a Discount for Lack of Marketability (DLOM) to reflect the illiquidity of unlisted shares before arriving at an equity value per share. The DLOM itself must be determined empirically for each engagement rather than defaulted to a standard rate, and documented with supporting evidence in the report.

4.4 Pre-Revenue Methods: Berkus and VC Method

For companies with no revenue history, traditional DCF and CCA methods cannot be applied directly. Two methods are used in practice:

Berkus Method

Assigns value to five qualitative drivers, each worth up to ₹50–100 lakh:

• Soundness of idea / validated market need

• Working prototype or technology

• Quality and completeness of founding team

• Strategic relationships or signed pilot agreements

• Near-term revenue visibility or product rollout plan

The Berkus Method is not a standalone IBBI-accepted methodology on its own  it must always be cross-checked against the last funding round’s implied valuation and reconciled in the report. Where the two diverge, standard practice is a weighted average, commonly 25% weight to Berkus and 75% to the funding round (adjusted for time elapsed since the round), explicitly explained in the valuation report.

VC Method

Estimates value by working backwards from a target exit: Current Value = Expected Exit Value / Required Return. Appropriate when a startup has a clear exit roadmap within 3–5 years. Requires explicit assumptions on exit multiple and holding period, all of which must be documented.

The methods above determine the value of the equity share  Component 1 of the two-component framework. The section that follows addresses Component 2: what the recipient’s non-cash contribution is actually worth.

5. Component 2: Valuing the Non-Cash Contribution

This section addresses the valuation of what the sweat equity recipient actually brings to the company: their IP, software, know-how, or expertise. This is where the most judgment-intensive work occurs, and where the quality of the valuation opinion is most visible.

5.1 Relief from Royalty Method (RfR)

Best suited for: Patents, trademarks, branded IP, proprietary technology with documented licensing comparables.

Methodology: Estimates the royalties the company would have paid if it had licensed the IP from a third party. IP Value = Projected Revenue × Royalty Rate, discounted to present value over the IP’s useful life. The royalty rate is the most judgment-intensive input: it must be sourced from published licensing databases such as kTMINE, RoyaltyStat, or MARKABLES, documented against the specific comparable licences selected, and justified relative to the IP’s maturity and exclusivity citing an ‘industry norm’ without a database source will not withstand scrutiny from the Income Tax Department.

5.2 Cost-to-Recreate Method

Best suited for: Proprietary software, code, internal systems, algorithms, and databases where the IP does not have directly comparable licences.

Methodology: Estimates what it would cost the company to replicate the technology from scratch by hiring equivalent talent, building up the cost of the team, time, infrastructure, and opportunity cost involved. The resulting figure functions as a value floor: the company should always be willing to pay at least this much for the contribution, so if the equity grant is worth less than the cost to recreate, the grant is almost certainly proportionate.

5.3 Multi-Period Excess Earnings Method (MEEM)

Best suited for: Complex IP that drives a specific, measurable portion of company revenues such as a proprietary algorithm, core platform technology, or flagship product. This is the methodology used by Big 4 valuation firms for sophisticated IP assignments.

Methodology: MEEM isolates the cash flows attributable to a specific IP asset after deducting Contributory Asset Charges (CACs)  the returns required by all other assets contributing to revenue typically 8–12% for working capital, 10–15% for tangible assets, 15–25% for assembled workforce, and 15–20% for other intangibles. The remainder represents excess earnings attributable solely to the IP, discounted at an IP-specific rate of roughly 20–35% for early-stage IP or 15–22% for mature IP.

5.4 Market Benchmarking Advisory and Expertise

Best suited for: When the contribution is know-how, strategic advisory, or industry connections rather than formal IP. The valuer researches what the company would have paid for equivalent advisory services in an arm’s-length arrangement.

This approach requires: documented market rates for comparable advisory services, specific description of services rendered, and quantification of measurable business outcomes (e.g., deals closed, partnerships formed, revenue attributable). Typically used for senior advisors, domain experts, and CXO-level contributions without formal IP.

5.5 NPV of Cost Savings Process Improvements

Best suited for: Manufacturing processes, operational improvements, or efficiency technologies where the contribution generates quantifiable annual savings.

Formula: IP Value = Annual Cost Savings × Discount Factor over Useful Life. The valuer projects the annual savings the contribution generates, discounts them to present value over the period for which the improvement remains effective, and adjusts for the risk that the projected savings are not fully realised.

6. Comprehensive Case Studies

Case Study 1: Early-Stage Deep Tech Startup

Parameter

Details

Company

QuantAI Robotics Pvt. Ltd.  AI-based agricultural drone company

Stage

Pre-revenue, 18 months old, seed funded (₹2Cr raised at ₹15Cr pre-money)

Sweat Equity Candidate

Dr. Meera Singh  IIT Bombay PhD, drone navigation algorithm inventor

Contribution

Core navigation IP (2 patents filed), 2 years full-time effort

Shares Proposed

5,00,000 equity shares (10% of post-issue capital)

Step 1: Component 1- Valuation of Company (Berkus + Funding Round Reconciliation)

Value Driver (Berkus Method)

Value Assigned

Soundness of idea / validated market need

₹50,00,000

Prototype / working technology

₹1,00,00,000

Quality of founding team

₹75,00,000

Strategic relationships / pilot agreements

₹50,00,000

Product rollout / near-term revenue visibility

₹25,00,000

Berkus Indicated Value

₹3,00,00,000

Reconciliation Berkus vs. Last Funding Round

The Berkus method yields ₹3Cr. However, the company’s last seed round valued it at ₹15Cr pre-money.

We apply a weighted average giving 25% weight to Berkus and 75% weight to the funding round (adjusted for 18 months’ progress since the round) to arrive at the ₹12Cr consensus equity value.

This is standard practice when Berkus and a funding round produce divergent values. The reconciliation must be explicitly explained in the valuation report with the weighting rationale documented.

FMV per share = ₹12,00,00,000 / 50,00,000 shares = ₹24 per share

Step 2: Component 2- IP Valuation (Relief from Royalty + Cost-to-Recreate)

• Relief from Royalty: Comparable navigation IP royalty rate (sourced from kTMINE) = 3.5% of revenues

• 10-year projected revenue NPV (probability-weighted) = ₹80Cr

• IP Value via RfR = 3.5% × ₹80Cr = ₹2.8Cr

• Cost-to-Recreate: 3 engineers × 2 years × ₹25L = ₹1.5Cr (establishes value floor)

• Weighted average of RfR and Cost-to-Recreate: ₹2.2Cr → Component 2 concluded value

Step 3: Proportionality Reconciliation

Value of 5,00,000 shares at ₹24 = ₹1.2Cr (Component 1 × shares). Component 2 concluded value = ₹2.2Cr. Since Component 2 (₹2.2Cr) > Component 1 grant value (₹1.2Cr), the equity grant is proportionate and defensible. The valuation conclusion holds.

Case Study 2: Listed Mid-Cap Company  Employee Sweat Equity

Parameter

Details

Company

Precision Engineering Ltd.  NSE-listed manufacturing company

Candidate

Mr. Rajan Khanna, Chief Innovation Officer

Contribution

Patented manufacturing process reduced production costs by 22%

Shares

2,00,000 equity shares (within 15% annual cap) | 3-year lock-in mandatory

Step 1: Component 1- FMV per Share (SEBI VWAP Formula)

Period

Average VWAP High (₹)

Average VWAP Low (₹)

2 weeks preceding relevant date

292

279

6 months preceding relevant date

295

275

Average of H/L  2 weeks

₹285.50

 

Average of H/L  6 months

₹285.00

 

FMV = Higher of the two (mandatory floor)

₹285.50 per share

 

Value of Sweat Equity Issued = 2,00,000 × ₹285.50 = ₹5,71,00,000 (₹5.71 Crore)

Step 2: Component 2- Process IP Valuation (NPV of Cost Savings + MEEM Cross-Check)

• Annual cost savings from process improvement: ₹8.5Cr per year

• Useful life of process innovation: 7 years

• NPV of savings discounted at 12%: ₹38.7Cr

• Proprietary value (after risk adjustment at 15%): ₹32.9Cr (Primary method concluded value)

MEEM Cross-Check

The process innovation drives approximately ₹8.5Cr annual incremental margin contribution.

After deducting contributory asset charges (working capital, fixed assets, workforce) at appropriate rates, excess earnings attributable to the IP = ₹6.2Cr/year.

Discounted at 18% over 7 years = ₹27.8Cr

Primary method (NPV of savings: ₹32.9Cr) and MEEM cross-check (₹27.8Cr) are consistent  this strengthens the valuation conclusion and demonstrates methodological rigour.

Step 3: Proportionality Reconciliation

Component 1 grant value = 2,00,000 × ₹285.50 = ₹5.71Cr. Component 2 (NPV of Savings) = ₹32.9Cr. Component 2 substantially exceeds the grant value  the grant is strongly defensible and proportionate.

Case Study 3: Series B Funded SaaS Company CTO Platform Contribution

Parameter

Details

Company

CloudStack Analytics Pvt. Ltd.  B2B SaaS analytics platform

Stage

Series B funded, ₹40Cr raised, ARR ₹30Cr, 3 years old

Candidate

Vikram Bose, CTO formalising equity for 3 years of platform-building

Contribution

Core ML analytics engine drives 35% of ARR; 4 proprietary algorithms

Shares Proposed

8,00,000 equity shares (8% of post-issue capital)

Step 1: Component 1- FMV per Share (DCF + EV/ARR Weighted)

• DCF: Projected FCFs over 5 years at WACC of 20% (built up: 7% + 7% + 4% + 2%) → Equity Value: ₹185Cr

• EV/ARR: Comparable SaaS peers trade at 5.5x–7.0x ARR; median 6.2x. Subject company ARR: ₹30Cr → EV: ₹186Cr → Equity Value: ₹181Cr

• DLOM: 18% (Series B stage, active secondary market). DLOC (Discount for Lack of Control): 10% (minority stake, no board seat)

• Weighted equity value: DCF ₹185Cr (60% weight) + CCA ₹181Cr (40% weight) = ₹183.4Cr

• After DLOM 18%: ₹150.4Cr | After DLOC 10%: ₹135.4Cr | Shares: 1,00,00,000 | FMV per share: ₹135.40

Step 2: Component 2- ML Engine Valuation (MEEM Primary, Cost-to-Recreate Floor)

• ML engine drives 35% of ARR = ₹10.5Cr attributable revenue | Operating margin: 40% → Operating income: ₹4.2Cr

• Less CACs: Working capital ₹0.3Cr + Fixed assets ₹0.4Cr + Workforce ₹0.6Cr + Other IP ₹0.3Cr = ₹1.6Cr

• Excess earnings attributable to ML engine: ₹2.6Cr/year | Discount rate (IP-specific): 22% | Useful life: 6 years

• MEEM Component 2 value: ₹9.1Cr

• Cost-to-Recreate cross-check: 6 ML engineers × 3 years × ₹35L = ₹6.3Cr (floor established consistent with MEEM)

Step 3: Proportionality Reconciliation

Component 1 grant value = 8,00,000 × ₹135.40 = ₹10.83Cr. Component 2 (MEEM) = ₹9.1Cr. Component 2 is close to but slightly below the grant value. The valuer documents: (i) the Cost-to-Recreate floor of ₹6.3Cr, (ii) the intangible contribution to platform reputation not captured in MEEM, and (iii) three years of institutional knowledge and team building. With this written justification, the grant at ₹10.83Cr is defensible  marginally above the MEEM value, but consistent with the totality of contribution.

This case illustrates the most common real-world scenario: a funded company formalising equity for a technical co-founder or CTO. The combination of DCF + CCA (Component 1) and MEEM + Cost-to-Recreate (Component 2) provides the most defensible methodology framework for this stage.

7. Conclusion

Sweat equity is one of the most powerful tools available to Indian startups and growth-stage companies. But its power is only realised when the valuation is rigorous, defensible, and built on the right methodology for the specific transaction.

The Three Golden Rules of Sweat Equity Valuation

Rule 1: GET THE METHODOLOGY RIGHT: The choice between DCF, CCA, NAV, MEEM, Relief from Royalty, and Cost-to-Recreate is not arbitrary. Match the method to the company’s stage, asset type, and data quality. A mismatched method produces a number not a defensible valuation.

Rule 2: VALUE BOTH COMPONENTS: FMV of the share alone is half the job. The non-cash contribution must be independently valued and explicitly reconciled against the equity grant. This proportionality conclusion is the linchpin of the entire opinion.

Rule 3: DOCUMENT THE ADJUSTMENTS: DLOM, DLOC, royalty rates, and comparable selection must all be evidenced, cited, and sensitivity-tested. A number without its basis is an estimate. A number with its basis is an opinion.

Sweat equity, valued properly and structured thoughtfully, is the bridge between a brilliant idea and a well-incentivised team that will make it real.

AUTHORED BY

Mr. Sanchit Vijay

Director & Head – Deals & Valuation Services

Chartered Accountant

sanchit@indiacp.com

9899636864

Sheetal Sharma

Analyst

.

sheetal.sharma@indiacp.com

Request a Call
Scroll